Alternative Antibiotic Regimens for Intra‑Abdominal Infections in β‑Lactam‑Allergic Patients

Preferred First‑Line Agent

Eravacycline 1 mg/kg IV every 12 h is the preferred alternative for β‑lactam‑allergic patients with intra‑abdominal infections, regardless of severity (including septic shock) when source control is adequate. [Italian guidelines, 2024] 1

Fluoroquinolone (ciprofloxacin or levofloxacin) + metronidazole may be used for mild community‑acquired intra‑abdominal infections in β‑lactam‑allergic patients, but should be limited because of widespread resistance. [World Journal of Emergency Surgery, 2017] 2, 3, 4
The fluoroquinolone must always be combined with metronidazole to ensure adequate anaerobic coverage. [World Journal of Emergency Surgery, 2017] 3, 4
Ertapenem 1 g IV every 24 h is an option when the reported β‑lactam allergy can be clarified (many reported allergies are not true IgE‑mediated reactions). [Italian guidelines, 2024; World Journal of Emergency Surgery, 2017] 1, 3, 4

For immunocompetent, non‑critically ill patients with adequate source control, a 4‑day course of antibiotics is sufficient. [Italian guidelines, 2024] 1
For immunocompromised or critically ill patients with adequate source control, therapy may be extended up to 7 days, guided by clinical status and inflammatory markers. [Italian guidelines, 2024] 1
If signs of infection persist beyond 7 days, a diagnostic work‑up (e.g., repeat imaging, culture) is required rather than simply prolonging antibiotics. [Italian guidelines, 2024] 1

Effective source control (surgical intervention, drainage, or debridement) is mandatory for antibiotics to be effective in complicated intra‑abdominal infections. [Italian guidelines, 2024] 1
In healthcare‑associated infections, critically ill patients, or those who have received prior antimicrobials, obtain intra‑operative peritoneal fluid/tissue specimens (≥1–2 mL) for culture. [World Journal of Emergency Surgery, 2017] 2
Send specimens for Gram stain, aerobic and anaerobic cultures, and susceptibility testing. [World Journal of Emergency Surgery, 2017] 2

De‑escalate therapy when culture results become available, narrowing the spectrum to the identified pathogen. [World Journal of Emergency Surgery, 2017] 2
De‑escalation helps reduce selective pressure for resistant organisms. [World Journal of Emergency Surgery, 2017] 2, 3
Fluoroquinolones must never be used without metronidazole for intra‑abdominal infections because they lack adequate anaerobic activity. [World Journal of Emergency Surgery, 2017] 3, 4
Extended use of fluoroquinolones should be discouraged due to the risk of selecting ESBL‑producing Enterobacteriaceae and MRSA. [World Journal of Emergency Surgery, 2017] 2

The American Heart Association explicitly states that clindamycin has been associated with infective endocarditis relapse and is not recommended for serious infections, and clindamycin is NOT recommended for intra-abdominal/bowel infections in beta-lactam allergic patients due to high risk of treatment failure, C. difficile infection, and inferior outcomes compared to alternative agents 5, 6

Eravacycline 1 mg/kg IV every 12 hours is the preferred alternative for both non-critically ill and critically ill patients 6
Tigecycline 100 mg loading dose, then 50 mg IV every 12 hours is an acceptable alternative 6
Fluoroquinolones (levofloxacin or ciprofloxacin) PLUS metronidazole may be considered for mild infections, though resistance patterns limit their use in many regions 7, 8

Determine if adequate source control has been achieved (surgical drainage, debridement, or repair) 6, 9
Classify patient as non-critically ill vs. critically ill/septic shock 6
Identify if patient is immunocompromised 6
For non-critically ill, immunocompetent patients with adequate source control: Eravacycline 1 mg/kg IV q12h OR Tigecycline 100 mg loading dose then 50 mg IV q12h 6
For critically ill or immunocompromised patients: Eravacycline 1 mg/kg IV q12h (preferred even in septic shock) 6
Always perform intraoperative cultures in healthcare-associated infections or critically ill patients 7
De-escalate or adjust based on culture results and clinical response 7

If using fluoroquinolones, ALWAYS add metronidazole for anaerobic coverage in intra-abdominal infections 7, 8
Antimicrobial therapy alone is insufficient for complicated intra-abdominal infections, and surgical intervention or drainage must be adequate for antibiotics to be effective 6, 9
Patients with ongoing signs of infection beyond 7 days warrant diagnostic investigation, not simply continued antibiotics 6